MagForce Nanotechnologies AG announced today the publication of clinical data from a clinical study examining the safety and efficacy of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy in patients with recurrent glioblastoma multiforme.
Coherent, a world leader in providing laser-based solutions to the commercial and scientific research markets, and Holst Centre, an open-innovation initiative by imec and TNO today announce their cooperation in the field of flexible electronics.
Applied Nanotech Holdings, Inc. announced that it will showcase some of its key nanotechnology advancements in metallic inks and pastes at the NIP26 Digital Printing Technologies Conference being held at the Hilton Hotel in Austin, TX from September 21-23, 2010.
Having completed its qualification process, the customer has begun using Applied Seals' products within all of its chemical vapor deposition (CVD) and etching equipment at its wafer fabs and R+D facilities throughout Asia, the U.S. and Europe.
As of today, the LIBRA series Transmission Electron Microscopes (TEM) from Carl Zeiss take a leap forward by offering the new ZEMAS framework technology (ZEISS Electron Microscopy Applications Software).
Altair Nanotechnologies, Inc. (Altair) today announced that it reached a definitive agreement whereby Canon Investment Holdings Limited would purchase newly issued common shares of Altair Nanotechnologies, Inc. resulting in 51% of Altair's fully diluted common shares immediately following closing.
Taiwan Semiconductor Manufacturing Company, Ltd. (TSMC) broke ground in Taichung's Central Taiwan Science Park on the company's first Thin Film Solar R+D Center and Fab, laying the foundation for the company's entry into the thin-film solar photovoltaic market.
Vistec Lithography, Inc., a leading supplier of advanced electron-beam lithography systems, announced today that AMO GmbH, a research service provider for nanotechnology located in Aachen (Germany), has placed an order for Vistec's electron-beam lithography system EBPG5200.
FluimediX, a point-of-care diagnostic company, announced today that it has received funding for the continued development of the NanoCycler, a diagnostic platform for the measurement of relevant genetic mutations in patients.